Crestor
« Previous EntriesRosuvastatin treatment ‘cost-effective’ and ‘may be cost-saving’
Monday, February 21st, 2011Source: MedWire News
Rosuvastatin treatment in JUPITER-eligible patients appears to be cost-effective and has the potential to be cost-saving, suggest findings of a study published in the Journal of the American College of Cardiology.
Niteesh Choudhry (Harvard Medical School, Boston, Massachusetts, USA) and colleagues say that treating apparently healthy patients with normal low-density lipoprotein (LDL) cholesterol and elevated [...]
Heart Risk in One-Fifth of U.S. Teenagers Found by Lipid Tests
Thursday, January 21st, 2010A risk of heart disease in one-fifth of U.S. teenagers was identified through tests of lipids in the blood, showing the importance of diet, exercise and screening, according to U.S. researchers.
Obese children were at the highest danger of abnormal lipid levels, with 43 percent testing outside the recommended ranges, according to today’s report by the U.S. Centers [...]
FDA approves Crestor for younger patients with familial hypercholesterolemia.
Monday, October 19th, 2009The AP (10/16) reported that “the Food and Drug Administration approved AstraZeneca PLC’s cholesterol drug Crestor [rosuvastatin] for use by children and teenagers with a genetic disease” called heterozygous familial hypercholesterolemia. The condition “affects 10 million people worldwide, and causes high levels of…LDL cholesterol.”
HeartWire (10/16, O’Riordan) reported that “the approval is [...]
Statins Benefit People With Low, High Cholesterol
Monday, September 28th, 2009Statin therapy may be as effective in reducing heart attack, stroke, the need for artery-opening procedures, or heart-related death in people with normal or even low cholesterol but elevated high sensitivity C-reactive protein (hsCRP) as in patients with high cholesterol, according to research reported in Circulation: Cardiovascular Quality and Outcomes, a journal of the American [...]
Statins Before Vascular Surgery Cut Deaths, Complications
Wednesday, September 2nd, 2009Source: HealthDay News
A dose of a cholesterol-lowering statin before vascular surgery reduces the risk of complications and death, new Dutch research shows.
The study of nearly 500 patients who had surgery for a variety of blood-vessel problems found the incidence of heart artery blockage and deaths was halved in those who received an 80-milligram dose of [...]
Astra’s Crestor shows preventive effect in elderly
Monday, August 31st, 2009Source: Reuters
* Over 70s see 39 pct risk reduction in trial
Â
* New analysis may widen drug use in elderly
AstraZeneca’s anti-cholesterol drug Crestor cuts the risk of heart attacks, strokes, artery-clearing procedures and death in apparently healthy elderly patients, as well as those who are middle-aged.
A new analysis of the so-called Jupiter study, released on Monday at [...]
Heart Disease: Combined Treatment Is Best
Thursday, March 26th, 2009Heart Patients Fare Better When They Fix Both Blood Pressure and Cholesterol, Study Shows
Source: Web MD
Heart disease patients who achieve normal blood pressure and very low cholesterol levels with aggressive drug therapy do better than patients who achieve only one of these goals, new research suggests.
Using ultrasound to identify plaque buildup within the artery walls [...]
Alternate day dosing of rosuvastatin
Thursday, March 12th, 2009Daily dosing of rosuvastatin (Crestor) provides statistically better LDL-C lowering than alternate daily dosing, according to the results of a new study. Rosuvastatin has a longer half-life than other statins, which led the authors to examine the feasibility of alternate daily dosing.
The crossover study compared rosuvastatin 20 mg every other day to rosuvastatin 10 mg [...]
Do cholesterol drugs really work?
Friday, February 27th, 2009DEAR DR. DONOHUE: I read a cover story in a national magazine that claimed there is much question about the need to lower cholesterol and to prescribe statin medicines. I can’t believe this story wasn’t front-page news, since 18 million Americans take statin drugs. People taking statins are exposed to the risks of muscle pain, [...]
Steady Cholesterol-Pill Use Found to Cut Death Risk Almost Half
Tuesday, February 10th, 2009Continuous treatment with cholesterol pills, such as Pfizer Inc.’s Lipitor, reduced the risk of death in patients with high cholesterol 45 percent over four to five years, a study found.
People who hadn’t yet been diagnosed with heart disease and those who had already been diagnosed both showed the reduction in death if they took the [...]
